Cargando…
The role of (18)F-FDG-PET in detecting Richter transformation of chronic lymphocytic leukemia in patients receiving therapy with a B-cell receptor inhibitor
Autores principales: | Wang, Yucai, Rabe, Kari G., Bold, Michael S., Shi, Min, Hanson, Curtis A., Schwager, Susan M., Call, Timothy G., Kenderian, Saad S., Muchtar, Eli, Hayman, Suzanne R., Koehler, Amber B., Fonder, Amie L., Chanan-Khan, Asher A., Van Dyke, Daniel L., Slager, Susan L., Kay, Neil E., Ding, Wei, Leis, Jose F., Parikh, Sameer A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604634/ https://www.ncbi.nlm.nih.gov/pubmed/33131260 http://dx.doi.org/10.3324/haematol.2019.240564 |
Ejemplares similares
-
Clinical characteristics and outcomes of Richter transformation: experience of 204 patients from a single center
por: Wang, Yucai, et al.
Publicado: (2020) -
Distinct immune signatures in chronic lymphocytic leukemia and Richter syndrome
por: Wang, Yucai, et al.
Publicado: (2021) -
The impact of dose modification and temporary interruption of ibrutinib on outcomes of chronic lymphocytic leukemia patients in routine clinical practice
por: Parikh, Sameer A., et al.
Publicado: (2020) -
Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinib
por: Hampel, Paul J., et al.
Publicado: (2022) -
Cause of death in patients with newly diagnosed chronic lymphocytic leukemia (CLL) stratified by the CLL-International Prognostic Index
por: Wang, Yucai, et al.
Publicado: (2021)